Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter
Healthcare AI Acquisition Corp. (NASDAQ:HAIA), a special purpose acquisition company, has received a notification letter from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1). The company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024. Under Nasdaq rules, HAIA has 60 calendar days to submit a compliance plan. If accepted, Nasdaq may grant an extension of up to 180 calendar days from the Form 10-Q's due date, until December 12, 2024, to regain compliance. The company intends to file the Form 10-Q promptly to address this issue. This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires disclosure of deficiency notifications.
Healthcare AI Acquisition Corp. (NASDAQ:HAIA), una società di acquisizione per scopi speciali, ha ricevuto una lettera di notifica da Nasdaq che indica la non conformità alla Regola di Quotazione 5250(c)(1). La società non è riuscita a presentare in tempo il suo Rapporto Trimestrale sul Modulo 10-Q per il periodo conclusosi il 31 marzo 2024. Secondo le regole di Nasdaq, HAIA ha 60 giorni di calendario per presentare un piano di conformità. Se accettato, Nasdaq può concedere un'estensione fino a 180 giorni di calendario dalla data di scadenza del Modulo 10-Q, fino al 12 dicembre 2024, per ripristinare la conformità. La società intende presentare prontamente il Modulo 10-Q per affrontare questa questione. Questo annuncio viene fatto in conformità con la Regola di Quotazione Nasdaq 5810(b), che richiede la divulgazione delle notifiche di carenza.
Healthcare AI Acquisition Corp. (NASDAQ:HAIA), una compañía de adquisición de propósito especial, ha recibido una carta de notificación de Nasdaq indicando incumplimiento de la Regla de Cotización 5250(c)(1). La compañía no logró presentar a tiempo su Informe Trimestral en el Formulario 10-Q para el período que finalizó el 31 de marzo de 2024. De acuerdo con las reglas de Nasdaq, HAIA tiene 60 días naturales para presentar un plan de cumplimiento. Si es aceptado, Nasdaq puede conceder una prórroga de hasta 180 días naturales a partir de la fecha de vencimiento del Formulario 10-Q, hasta el 12 de diciembre de 2024, para recuperar el cumplimiento. La compañía tiene la intención de presentar el Formulario 10-Q con prontitud para abordar este problema. Este anuncio se realiza en cumplimiento de la Regla de Cotización de Nasdaq 5810(b), que requiere la divulgación de notificaciones de deficiencia.
Healthcare AI Acquisition Corp. (NASDAQ:HAIA)는 특수 목적 인수 회사로서, 나스닥으로부터의 통지서를 받았으며, 이는 5250(c)(1) 상장 규정을 준수하지 않았음을 나타냅니다. 회사는 2024년 3월 31일 종료된 분기에 대한 10-Q 양식 분기 보고서를 정시 제출하지 못했습니다. 나스닥 규정에 따르면, HAIA는 준수 계획을 제출하기 위해 60일의 일정 기간이 있습니다. 만약 수용된다면, 나스닥은 10-Q 양식 마감일로부터 최대 180일의 연장을 허가할 수 있으며, 이는 2024년 12월 12일까지 준수를 회복할 수 있도록 합니다. 회사는 이 문제를 해결하기 위해 10-Q 양식을 즉시 제출할 계획입니다. 이 발표는 결함 통지를 공개하도록 요구하는 나스닥 상장 규정 5810(b)에 따라 이루어졌습니다.
Healthcare AI Acquisition Corp. (NASDAQ:HAIA), une société d'acquisition à but spécial, a reçu une lettre de notification de Nasdaq indiquant un non-respect de la Règle de Cotation 5250(c)(1). L'entreprise n'a pas déposé à temps son Rapport Trimestriel sur le Formulaire 10-Q pour la période se terminant le 31 mars 2024. Selon les règles de Nasdaq, HAIA a 60 jours calendaires pour soumettre un plan de conformité. Si accepté, Nasdaq peut accorder une prolongation allant jusqu'à 180 jours calendaires à partir de la date d'échéance du Formulaire 10-Q, jusqu'au 12 décembre 2024, pour rétablir la conformité. L'entreprise a l'intention de déposer le Formulaire 10-Q rapidement pour résoudre ce problème. Cette annonce est faite en conformité avec la Règle de Cotation Nasdaq 5810(b), qui exige la divulgation des notifications de carence.
Healthcare AI Acquisition Corp. (NASDAQ:HAIA), eine Gesellschaft zur Akquisition zu besonderen Zwecken, hat ein Benachrichtigungsschreiben von Nasdaq erhalten, das auf die Nichteinhaltung der Listing-Regel 5250(c)(1) hinweist. Das Unternehmen hat es versäumt, rechtzeitig seinen Quartalsbericht auf dem Formular 10-Q für das am 31. März 2024 endende Quartal einzureichen. Nach den Nasdaq-Regeln hat HAIA 60 Kalendertage Zeit, um einen Compliance-Plan einzureichen. Wenn akzeptiert, kann Nasdaq eine Verlängerung von bis zu 180 Kalendertagen ab dem Fälligkeitsdatum des Formulars 10-Q gewähren, bis zum 12. Dezember 2024, um die Einhaltung wiederherzustellen. Das Unternehmen plant, das Formular 10-Q umgehend einzureichen, um dieses Problem anzugehen. Diese Ankündigung erfolgt gemäß der Nasdaq-Listing-Regel 5810(b), die die Offenlegung von Mängelmitteilungen erfordert.
- Company intends to file Form 10-Q promptly to regain compliance
- Nasdaq may grant up to 180 days extension to regain compliance
- Failure to timely file Quarterly Report on Form 10-Q
- Received Nasdaq deficiency letter for non-compliance with listing rules
- Risk of potential delisting if compliance is not regained
NEW YORK, NY / ACCESSWIRE / July 19, 2024 / Healthcare AI Acquisition Corp. (NASDAQ:HAIA) (the "Company"), a special purpose acquisition company, announced today that it received a notification letter from The Nasdaq Stock Market ("Nasdaq") that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q"). Under the Nasdaq Listing Rules, the Company now has 60 calendar days to submit a plan to regain compliance and if the plan is accepted, Nasdaq may grant an exception of up to 180 calendar days from the Form 10-Q's due date, or until December 12, 2024, to regain compliance. The Company intends to file its Form 10-Q as promptly as possible to regain compliance with the Rule.
This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires disclosure of receipt of a deficiency notification.
About Healthcare AI Acquisition Corp.
Healthcare AI Acquisition Corp. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Forward Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.
Contacts
Healthcare AI Acquisition Corp.
Xiaocheng Peng
pengxc0324@gmail.com
SOURCE: Healthcare AI Acquisition Corp.
View the original press release on accesswire.com
FAQ
Why did Healthcare AI Acquisition Corp. (HAIA) receive a Nasdaq deficiency letter?
What is the deadline for Healthcare AI Acquisition Corp. (HAIA) to submit a compliance plan to Nasdaq?
How long does Healthcare AI Acquisition Corp. (HAIA) have to regain compliance with Nasdaq listing rules?
What action is Healthcare AI Acquisition Corp. (HAIA) taking to address the Nasdaq deficiency notice?
